Hidetoshi Yasuda

Comparative Prognostic Value of Four Urinary Biomarkers for Cardiovascular and Renal Outcomes after Transcatheter Aortic Valve Implantation

Hidetoshi Yasuda, Hiroshi Iwata, Shinichiro Doi, Takuma Koike et autres

Introduction: Renal risk stratification after transcatheter aortic valve implantation (TAVI) remains anchored to filtration metrics such as serum creatinine and estimated glomerular filtration rate (eGFR). These indices may not capture early tubular injury, which is clinically relevant in older TAVI populations. We …

jp (code pays fourni par la source)

Elevated levels of plasma inactive stromal cell derived factor-1α predict poor long-term outcomes in diabetic patients following percutaneous coronary intervention

Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito et autres

BACKGROUND: Since the complication of diabetes mellitus (DM) is a risk for adverse cardiovascular outcomes in patients with coronary artery disease (CAD), appropriate risk estimation is needed in diabetic patients following percutaneous coronary intervention (PCI). However, there is no useful biomarker to …

jp (code pays fourni par la source)

あん摩マッサージ指圧・はり・きゅう施術所を経営する視覚障害者の意識や行動、心理特性に関する質的研究－ 一定額以上の売り上げがあるケースから－

Hidetoshi Yasuda

Impact of Low-Dose Prasugrel on Platelet Reactivity in Chronic Phase of Post-Percutaneous Coronary Intervention (CHAPERON): a Prospective Cohort Study

Tatsuya Fukase, Shinichiro Doi, Tomotaka Dohi, Takuma Koike et autres

jp (code pays fourni par la source)

Impact of low-dose prasugrel on platelet reactivity in chronic phase of post-percutaneous coronary intervention (CHAPERON): a prospective cohort study

Tatsuya Fukase, Shinichiro Doi, Tomotaka Dohi, Takuma Koike et autres

Abstract Purpose Asians often face the problems of clopidogrel resistance and East Asian paradox. This study aimed to evaluate the effects of P2Y12 inhibitors, including low-dose prasugrel 2.5 mg, on the P2Y12 reaction unit (PRU) in the chronic phase after percutaneous coronary …

jp (code pays fourni par la source)

Favorable Prognosis in Patients with Recovered Pulmonary Hypertension after TAVI: An Analysis of the LAPLACE-TAVI Registry

Takuma Koike, Hiroshi Iwata, Yuichi Chikata, Shinichiro Doi et autres

Pulmonary hypertension (PH) is a common complication of aortic stenosis (AS). Despite the established association between PH and poor outcomes in patients with AS, the prognostic implication of a change in PH after transcatheter aortic valve implantation (TAVI) has been rarely evaluated. …

jp (code pays fourni par la source)

Capture of Part of a Vessel Wall by a Coronary Orbital Atherectomy System

Hidetoshi Yasuda, Kikuo Isoda, Shinya Okazaki, Tohru Minamino

An 82-year-old man who had undergone coronary artery bypass grafting, aortic/mitral valve replacement, and tricuspid valvuloplasty was seen for exertional angina. On angiography, a severely stenotic lesion of the distal left internal thoracic artery (LITA) was noted, which was a bypass graft …

jp (code pays fourni par la source)

Dipeptidyl peptidase-4 inhibitors reduced long-term cardiovascular risk in diabetic patients after percutaneous coronary intervention via insulin-like growth factor-1 axis

Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Takuma Koike et autres

Dipeptidyl-peptidase-4 inhibitors (DPP4i) have been the most used antidiabetic medications worldwide due to their good safety profiles and tolerability with a low risk of hypoglycemia, however, large cardiovascular outcome trials (CVOTs) have not shown any significant the prognostic superiority. On the contrary, …

jp (code pays fourni par la source)

Long-Term Impact of β-Blocker in Elderly Patients Without Myocardial Infarction After Percutaneous Coronary Intervention

Tatsuya Fukase, Tomotaka Dohi, Takuma Koike, Hidetoshi Yasuda et autres

AIMS: Little is known about the long-term outcomes of β-blockers use in patients with coronary artery disease (CAD) without myocardial infarction (MI) and reduced ejection fraction (rEF). However, more attention should be paid to the oral administration of β-blockers in elderly patients …

jp (code pays fourni par la source)

Abstract 10942: Comparison of Long-Term Prognostic Impact of 6 Major Cardiovascular Drugs in Patients Following Coronary Intervention; Analysis from the Registry Database with the 35-Year History

Hidetoshi Yasuda, Hiroshi Iwata, Takuma Koike, Yuichi Chikata et autres

Introduction: The evidence-based optimal medical therapy has been encouraged in the treatment of patients with coronary artery disease. However, as follow-up periods are limited (-5 years) in the most of randomized trials, prognostic efficacy of drugs in longer time period has not …

jp (code pays fourni par la source)

Abstract 13183: Persistent Anemia Was Associated With Higher Long-Term Mortality in Patients With Chronic Kidney Disease Following Primary Percutaneous Coronary Intervention

Takuma Koike, Yuichi Chikata, Hiroshi Iwata, Hidetoshi Yasuda et autres

Background: Anemia is one of the most common complications of chronic kidney disease (CKD), renal anemia, which has a significant link with increased risk of the morbidity, as well as the mortality of cardiovascular disease. However, the prognostic implication of the temporal …

jp (code pays fourni par la source)

Dipeptidyl Peptidase-4 Inhibitors Reduced Long-term Cardiovascular Risk in Japanese Diabetic Patients After Percutaneous Coronary Intervention via Insulin-like Growth Factor-1 Axis: A 10-year Follow-up Study

Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Takuma Koike et autres

Abstract Background: Dipeptidyl-peptidase-4 inhibitors (DPP4i) have become one of the most used antidiabetic medications worldwide due to their good safety profiles and tolerability with a low risk of hypoglycemia, however, no large cardiovascular outcome trials (CVOTs) have shown any significant superiority with …

jp (code pays fourni par la source)